Daily36m
SGLT2 Inhibitors versus DPP4 Inhibitors: Lower Nephrolithiasis Risk Found in Diabetes Patients, Study Finds
The study revealed a lower risk of nephrolithiasis with SGLT2 inhibitors than DPP4 inhibitors in both stone never-formers and ...